Current treatment of malignant hypertension.
D000208:Acute Disease; D000284:Administration, Oral; D000959:Antihypertensive Agents / Q000008:administration & dosage / Q000494:pharmacology; D001794:Blood Pressure / Q000187:drug effects; D003981:Diazoxide / Q000627:therapeutic use; D004232:Diuretics / Q000627:therapeutic use; D004630:Emergencies; D006145:Guanethidine / Q000627:therapeutic use; D006801:Humans; D006974:Hypertension, Malignant / Q000175:diagnosis / Q000188:drug therapy*; D007273:Injections, Intramuscular; D007275:Injections, Intravenous; D008750:Methyldopa / Q000627:therapeutic use; D009599:Nitroprusside / Q000627:therapeutic use; D011379:Prognosis; D011433:Propranolol / Q000627:therapeutic use; D012110:Reserpine / Q000627:therapeutic use
D000959:Antihypertensive Agents; D004232:Diuretics; D009599:Nitroprusside; D008750:Methyldopa; D012110:Reserpine; D011433:Propranolol; D003981:Diazoxide; D006145:Guanethidine